Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments

Table 7

Amastigotes antigens in immunoblottings, revealed by 80–100% sera, from patients with active CL, after clinical remission, and healthy controls.

Antigens (kDa) revealed by sera from patients with CL and controls (patients)a
Active (10)				Remission (10)				Control IDR− (7)
La	Lb	Lv	Lch	La	Lb	Lv	Lch	La	Lb	Lv	Lch
22^∗∗∗	17^∗	22^∗∗∗	35^∗∗∗	22^∗∗∗	22^∗∗∗	33^∗	33^∗	𝟏𝟕	17^∗	𝟐𝟗	33^∗
33^∗	22^∗∗∗	33^∗	40^∗∗∗	33^∗	35^∗∗∗	35∗∗∗	50^∗	33^∗	29^∗	33^∗	𝟒𝟓
35^∗∗∗	29^∗	35^∗∗∗	50^∗	35^∗∗∗	40^∗∗∗	50^∗	65^∗	𝟒𝟓	33^∗	𝟒𝟓	50^∗
40^∗∗∗	33^∗	40^∗∗∗	57^∗	40^∗∗∗	50^∗	74^∗	74^∗	50^∗	𝟒𝟓	50^∗	57^∗
50^∗	35^∗∗∗	50^∗	74^∗	50^∗	65^∗	80^∗∗	86∗∗	57^∗	50^∗	65^∗	65^∗
57^∗	40^∗∗∗	65^∗	80^∗∗∗	57^∗	74^∗∗∗	90^∗	90^∗∗∗	65^∗	65^∗	74^∗	74^∗
65^∗	50^∗	74^∗	86^∗	65^∗	98^∗∗∗	98^∗	98^∗	86	90^∗	86	86^∗
74^∗∗∗	57^∗∗∗	80^∗∗∗	90^∗∗∗	74^∗∗∗	104^∗∗∗		104^∗∗∗	90	𝟗𝟔	90^∗	98^∗
80^∗∗∗	65^∗		98^∗	100^∗∗	108^∗∗			98^∗	128	98^∗
98^∗	74^∗∗∗		104^∗∗∗					128^∗	132
100^∗∗∗	80^∗∗∗		128^∗∗
104^∗∗∗	86^∗∗∗
128^∗	90^∗
132^∗∗	98^∗∗∗
	100^∗∗∗
	104^∗∗∗
	115^∗∗
Total number of antigens in immunoblottings
La	Lb	Lv	Lch	La	Lb	Lv	Lch	La	Lb	Lv	Lch
Active lesions				Clinical remission				Healthy controls
14	17	8	11	9	9	7	8	10	10	9	8

aCommon bands present in each Leishmania species in active, or remission and control IDR− groups(∗). MW bands revealed by sera from active and clinical remission in same patients, not found by sera from controls at the respective homologous Leishmania specie(∗∗∗). Specific antigens found in one leishmania specie only in active or remission group, respectively(∗∗).